Di Lorenzo et al., reporting on 76 patients with androgen-dependent and -independent prostate cancer, observed 41%, 76% and 100% EGFR expression in radical prostatectomy, hormone-sensitive and hormone-refractory metastatic patients, respectively [24]. The gene discussed is EGFR; the disease is Familial prostate cancer.